Advanced Micro Devices is a semiconductor company. The company primarily provides x86 microprocessors, as standalone devices or as incorporated into an accelerated processing unit, chipsets, graphics processing units (GPUs), data center and personnel GPUs, and development services; server and embedded processors, semi-custom System-on-Chip products, development services and technology for game consoles. The company also licenses portions of its intellectual property portfolio. The company's segments are: Computing and Graphics, which consists of desktop, notebooks, commercial, and chipsets products; and Enterprise, Embedded and Semi-Custom, which includes server processors, and embedded P\processors products.

Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. The company develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company's main capabilities include clinical development, vector discovery, and in-house manufacturing expertise, specifically in scalable process development, assay development, and current Good Manufacturing Practices quality control. The company is conducting a clinical trial for its gene therapy candidate ADVM-022, AAV.7m8-aflibercept, for the treatment of wet age-related macular degeneration.

Ascendant Resources is a resource company engaged in the exploration of gold and copper in the Popondetta Area of the Owen Stanley Range Papua New Guinea.

Beta Drugs Ltd. Beta Drugs Limited is an India-based pharmaceutical formulation manufacturing company. The Company is engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Company also engaged manufacturing oncology products. The Company offers a range of products including anti-cancer tablets, capsules, injections and lyophilized injections. The Company's portfolio over 50 products catering to various oncology diseases including breast, brain, bone, lung, mouth,head, and neck,prostate, haematology, cervics, and oeaophagus. The Company's oncology portfolio includes brands like Admine, Adgef, Addplatin, and Erlotad.

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies.

Black Knight is a provider of software, data and analytics solutions to the mortgage and consumer loan, real estate and capital market verticals. The company's solutions facilitate and automate business processes across the homeownership lifecycle. The company's business is organized into two segments: Software Solutions, which provides software and hosting solutions that facilitate and automate business processes across the homeownership lifecycle; and Data and Analytics, which supports the company's software solutions and is designed to help lenders and servicers make informed decisions, improve performance, identify and predict risk and generate qualified leads.

Brown-Forman primarily manufactures, bottles, imports, exports, markets, and sells a range of alcoholic beverage brands. Co.'s principal brands include, among other, Jack Daniel's Tennessee Whiskey; Jack Daniel's Tennessee Honey; Jack Daniel's RTDs; Gentleman Jack Rare Tennessee Whiskey; Jack Daniel's Tennessee Fire; Jack Daniel's Single Barrel Collection; Jack Daniel's Winter Jack; Jack Daniel's Sinatra Select; Jack Daniel's No. 27 Gold Tennessee Whiskey; Jack Daniel's Tennessee Rye; Korbel California Champagnes; Korbel California Brandy; Woodford Reserve Kentucky Bourbon; Woodford Reserve Double Oaked; Woodford Reserve Kentucky Rye Whiskey; Finlandia Vodkas; and Slane Irish Whiskey.

Ceridian HCM Holding is a holding company. Through its subsidiaries, the company is a human capital management (HCM) software company. Dayforce, the company's cloud HCM platform, provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. In addition to Dayforce, the company sells Powerpay, a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels. The company also continues to support customers using its Bureau solutions, which it generally stopped selling to new customers. The company invests in maintenance and necessary updates to support its Bureau customers and continues to migrate them to Dayforce.

Coupa Software is a provider of business spend management (BSM) solutions. The company provides a cloud-based BSM platform that delivers a range of capabilities that would typically require the purchase and use of multiple disparate point applications. The company's main platform consists of procurement, invoicing, expense management and payments modules that form the transactional engine for managing a company's business spend. In addition, the company's platform provides supporting modules to help companies further manage their spend, including strategic sourcing, spend analysis, contract management, supplier management, and contingent workforce management.

Guidewire Software provides a technology platform, composed of software, services, and a partner ecosystem, for the property and casualty insurance industry. Guidewire InsurancePlatform? consists of cloud and on-premise applications to support core operations, data management and analytics, and digital engagement and is connected to various data sources and third party applications. The company's operational platforms include: Guidewire InsuranceSuite, which comprises of PolicyCenter, BillingCenter, and ClaimCenter applications; and Guidewire InsuranceNow, which provides policy, billing and claims management functionality to insurers that prefer to subscribe to a cloud-based, all-in-one solution.

Kinsale Capital Group is an insurance holding company. The company focuses on the excess and surplus lines (E&S) market in the U.S., where it can use its underwriting capability to write coverages for hard-to-place small business risks and personal lines risks. The company's segment, Excess and Surplus Lines Insurance segment provides property and casualty insurance products through the E&S market. The company's commercial lines offerings include construction, small business, excess casualty, energy, product liability, general casualty, allied health, professional liability, life sciences, commercial property, management liability, health care, environmental, inland marine, public entity, and commercial insurance.

Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. The company's key product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. The company's second product candidate is KO-947, a selective small molecule inhibitor of extracellular signal related kinase, which the company is developing as a potential treatment for patients with tumors that have dysregulated activity due to mutations or other mechanisms in the mitogen-activated protein kinase pathway. The company's third product candidate is KO-539, a selective small molecule inhibitor of the menin-mixed lineage leukemia, protein-protein interaction.

LendingTree operates the online consumer platform. Services include mortgage loans, mortgage refinances, home equity loans and lines of credit, auto loans, and other related offerings. The company's segments include: Home, in which it partners with lenders throughout the United States to provide geographic lending coverage and to provide a suite of loan offerings on its marketplace; Consumer which provides consumer lending products on its online marketplace and non-lending Consumer products; and Insurance, which includes information, tools and access to insurance quote products, including home and automobile, through which consumers are matched with insurance aggregators to obtain insurance offers.

LiveRamp Holdings is a global technology company. The company provides enterprise customer management platform that help organizations utilize customer data to deliver products and experiences. A main component of the company's platform is the omnichannel, deterministic identity graph. Utilizing the company's identity graph, the LiveRamp platform resolves a customer's data (first-, second-, or third-party) to consumer identifiers that represent real people in a way that protects consumer privacy.

Lumentum Holdings is a provider of optical and photonic products addressing a range of end-market applications including Optical Communications (OpComms) and Commercial Lasers (Lasers) for manufacturing, inspection and life-science applications. The company's segments are: OpComms, which include a range of components, modules and subsystems to support customers including carrier networks of access, metro, long-haul and submarine applications; and Lasers, which provides lasers for the industrial and scientific markets used in a range of original equipment manufacturer applications including diode-pumped solid-state, fiber, diode, direct-diode and gas lasers such as argon-ion and helium-neon lasers.

MAG Silver is an exploration company conducting work on mineral properties it has staked or acquired by way of option agreement, principally in Mexico. Co. has not yet determined whether the properties on which it is conducting exploration contain any ore reserves that are economically recoverable. The recoverability of these amounts is dependent upon the existence of economically recoverable reserves, Co.'s ability to obtain the necessary financing to complete the development of the interests, and future profitable production, or alternatively, upon Co.’s ability to dispose of its interests on a profitable basis.

Masi Agricola Spa. Masi Agricola SpA (Masi) is an Italy-based company engaged in the distillers and wineries industry. The Company produces and distributes wines. It uses native grapes and indigenous methods from the Venetian territories. Masi Agricola SpA's products portfolio encompasses red dessert wines, dry red wines, white wines and sparkling wines. In addition, the Company manufactures traditional agricultural products, including balsamic vinegars, acacia honey, cherry jams, hand-made using peeled chestnuts mixed with sugar and cooked, as well as rice. It operates through Canova Srl, Societa Agricola Canevel Srl, Canevel Spumanti SpA and Canevel Spumanti Tenuta Le VigneSocieta Agricola Srl.

Mirati Therapeutics is a clinical-stage oncology company developing product candidates to address the genetic and immunological promoters of cancer. The company's KRAS inhibitor program is focused on developing inhibitors of KRAS mutations and includes one clinical candidate and a preclinical program. The company also has additional preclinical programs which include product candidates designed to address mutations and tumors where few treatment options exist. The company's clinical and preclinical programs consist of two product candidates: sitravatinib, a multi-kinase inhibitor and MRTX849, a KRAS G12C inhibitor. The company has several discovery programs, including a preclinical program for a KRAS G12D inhibitor.

Model N is a provider of cloud revenue management solutions for life sciences and technology companies. The company provides solutions that span the organizational and operational boundaries of functions such as sales, marketing, and finance and serve as a system of record for key revenue management processes including pricing, quoting, contracts, rebates, incentives, channel management, reporting and regulatory compliance. The company's solutions are purpose-built for the life sciences and technology industries and are designed to work with enterprise resource planning and customer relationship management applications that do not typically provide revenue management capabilities.

Nevro is a medical device company that has developed and commercialized the Senza? spinal cord stimulation, a neuromodulation platform for the treatment of chronic pain. The Senza system is approved to create electrical impulses from two Hz to 10,000 Hz, including the company's proprietary HF10 therapy, which allows for pain relief without paresthesia. Senza is consisted of leads, a trial stimulator, an implantable pulse generator (IPG), surgical tools, a clinician laptop programmer, a patient remote control and a mobile charger. These components enable physicians to implant the leads and the IPG, and patients to operate the system.

Palomar is a holding company. Through its subsidiaries, the company provides specialty property insurance. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, specialty homeowners, commercial all-risk, hawaii hurricane, residential flood, and real estate investor.

Pegasystems develops, markets, licenses, hosts, and supports enterprise software applications that help organizations transform the way they engage with their customers and process work across their enterprise. The company also licenses its low-code Pega Platform? for application development to clients to build and extend their own business applications. Pega Infinity? helps connect enterprises to their customers in real-time across channels, streamline business operations, and adapt to meet changing requirements. The company's applications and platform intersect with and encompass several software markets, including: customer engagement, digital process automation, and robotic process automation.

Proto Labs is a digital manufacturer of custom prototypes and production parts. The company's primary manufacturing product lines include Injection Molding, which uses three-dimensional (3D) computer-aided design-to-computer numerical control (CNC) machining technology for the automated design and manufacture of molds; CNC Machining, which uses commercially available CNC machines to provide milling and turning; 3D Printing, which includes stereolithography, selective laser sintering, direct metal laser sintering, Multi Jet Fusion and PolyJet processes; and Sheet Metal, which includes e-commerce-enabled custom sheet metal parts, providing customers with prototype and low-volume production parts.

PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. The company has the following products, Translarna? (ataluren) and Emflaza? (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. The company's gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC-AADC for the treatment of Aromatic L-Amino Acid Decarboxylase (AADC) deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.

Trupanion provides medical insurance for cats and dogs throughout the United States, Canada and Puerto Rico. The company operates in two business segments: subscription business and other business. The subscription business segment includes subscription fees for the company's medical insurance, which the company market to consumers. The other business segment is engaged in writing policies on behalf of third parties.

Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies. The company develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-na?ve and TKI-pretreated patients. The company's main drug candidate is repotrectinib (TPX-0005). In addition to repotrectinib, the company's pipeline includes two clinical-stage multi-targeted kinase inhibitors, TPX-0022 (a MET/CSF1R/SRC inhibitor) and TPX-0046 (a RET/SRC inhibitor), and a preclinical ALK inhibitor, TPX-0131, which is entering IND-enabling studies. The company's fourth drug candidate, TPX-0131 is a preclinical ALK inhibitor.

Vicor designs, develops, manufactures, and markets modular power components and power systems for converting electrical power. Reflecting its Power Component Design Methodology, the company provides a range of modular building blocks enabling design of a power system specific to a customer's needs. The company categorizes its product portfolios as either Advanced Products or Brick Products. The company also sells a range of electrical and mechanical accessories for use with its products. The Advanced Products category consists of products which are used to implement the company's proprietary Factorized Power Architecture?, a power distribution architecture. The Brick Products category consists of integrated power systems.

Vonage Holdings is a provider of cloud communications services for businesses and consumers. The company also provides a suite of residential communication solutions. For its Business customers, the company provides cloud-based Unified Communications as a Service solutions, comprised of integrated voice, text, video, data, collaboration, and mobile applications over its Session Initiation Protocol based Voice over Internet Protocol network. The company also provides Communications Platform as a Service solutions by embedding communications into apps, websites and business processes. For its Consumer customers, the company provides voice and messaging services and other features on a variety of devices.

Warrior Met Coal is a holding company. Through its subsidiaries, the company is a producer and exporter of met coal. The company sells its coal product to steel producers in Europe and South America. The company's mining operations consist of two underground met coal mines in Southern Appalachia's coal seam (Mines No. 7 and No. 4) and other surface met and thermal coal mines. The company's natural gas operations remove and sell natural gas from the coal seams owned or leased by the company and others as a byproduct of coal production. The company's degasification operations improve mining operations and safety by reducing natural gas levels in its mines. The company also owns mineral rights for recoverable reserves at its Blue Creek Energy Mine.

Y-mAbs Therapeutics is a biopharmaceutical company focused on the development and commercialization of antibody-based therapeutic products for the treatment of cancer. The company has a range of product pipeline, including two pivotal-stage product candidates: naxitamab and omburtamab, which target tumors that express GD2 and B7-H3, respectively. The company is developing naxitamab for the treatment of pediatric patients with relapsed or refractory, high-risk neuroblastoma (NB), and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system, leptomeningeal metastases, from NB.